Fylgia has advised Morimatsu at the listing in Hong Kong

Morimatsu International Holdings Ltd. (“Morimatsu”), with the Swedish subsidiary Pharmadule Morimatsu AB, was officially listed on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEx”) on 28 June 2021. With a solid market position in China, Morimatsu is committed to becoming the world’s leading critical pressure equipment manufacturer and engineering solutions provider. Fylgia advised Morimatsu on Swedish aspects regarding the listing.

Fylgia’s team was headed by partner Mattias Larsson (Head of M&A) and associate Jesper Linder.